DOCS.L

Dr. Martens plc
Dr. Martens PLC - Director/PDMR Shareholding
3rd June 2024, 08:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6928Q
Dr. Martens PLC
03 June 2024
 

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the "Company") announces that it has been notified of the following transaction in the Company's Ordinary 1p shares undertaken on behalf of a director / person discharging managerial responsibility ("PDMR").

Shortly after joining the Company on 13 May, Giles Wilson, Chief Financial Officer, received a cash payment to compensate him for the loss of bonuses he stood to receive at his previous employer. In line with the Company's Remuneration Policy, one third of the net amount payable was subsequently used to purchase shares which Giles is required to hold for a minimum of two years.

The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Giles Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary shares under the Global Bonus Scheme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.8745

73,145

d)

Aggregated information

-

Aggregated volume

-

Price

 

73,145

£0.8745

e)

Date of the transaction

2024-05-30

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAVARSAUVOAR]]>
TwitterFacebookLinkedIn